Your browser doesn't support javascript.
loading
Surgical Treatment for Type A Aortic Dissection after Endovascular Aortic Repair: A 12-year, Single-Center Study.
Xue, Yuan; Wang, Shipan; Zhang, Xuehuan; Wang, Xiaomeng; Shi, Yue; Zhang, Hongjia; Chen, Duanduan; Li, Haiyang.
Affiliation
  • Xue Y; Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Street, Beijing, 100029, Chaoyang District, China.
  • Wang S; Lung and Blood Vessel Diseases, Beijing Institute of Heart, Beijing, 100029, China.
  • Zhang X; Beijing Laboratory for Cardiovascular Precision Medicine, Beijing, 100029, China.
  • Wang X; Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Street, Beijing, 100029, Chaoyang District, China.
  • Shi Y; Lung and Blood Vessel Diseases, Beijing Institute of Heart, Beijing, 100029, China.
  • Zhang H; Beijing Laboratory for Cardiovascular Precision Medicine, Beijing, 100029, China.
  • Chen D; School of Life Science, Beijing Institute of Technology, Beijing, 100081, China.
  • Li H; Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Street, Beijing, 100029, Chaoyang District, China.
Article in En | MEDLINE | ID: mdl-38488985
ABSTRACT

OBJECTIVE:

This study aims to investigate the clinical manifestations, operative techniques, and outcomes of patients who undergo open repair after thoracic endovascular aortic repair (TEVAR).

METHODS:

From January 2010 to June 2022, 113 consecutive type A aortic dissection (TAAD) patients underwent secondary open operation after TEVAR at our institution, and the median interval from primary intervention to open surgery was 12 (1.9-48.0) months. We divided the patients into two groups (RTAD (retrograde type A dissection) group, N = 56; PNAD (proximal new aortic dissection) group, N = 57) according to their anatomical features. Survival analysis during the follow-up was evaluated using a Kaplan-Meier survival curve and a log-rank test.

RESULTS:

The 30-day mortality was 6.2% (7/113), the median follow-up period was 31.7 (IQR 14.7-65.6) months, and the overall survival at 1 year, 5 years, and 10 years was 88.5%, 88.5%, and 87.6%, respectively. Fourteen deaths occurred during the follow-up, but there were no late aorta-related deaths. Three patients underwent total thoracoabdominal aortic replacement 1 year after a second open operation. The RTAD group had a smaller ascending aorta size (42.5 ± 7.7 mm vs 48.4 ± 11.4 mm; P < .01) and a closer proximal landing zone (P < .01) compared to the PNAD group. However, there were no differences in survival between the two groups.

CONCLUSIONS:

TAAD can present as an early or a late complication after TEVAR due to stent-grafting-related issues or disease progression. Open operation can be performed to treat TAAD, and this has acceptable early and mid-term outcomes. Follow-up should become mandatory for patients after TEVAR because these patients are at increased risk for TAAD.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cardiovasc Drugs Ther Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cardiovasc Drugs Ther Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Type: Article Affiliation country: China